Purpose: To describe complications and visual outcome of photocoagulation f
or clinically significant macular oedema,
Subjects and Methods: Evaluation of macular oedema and complications of pho
tocoagulation in 194 eyes, defined as subretinal fibrosis, atrophic creep o
f the pigment epithelium and subretinal neovascularization was based on ste
reo fundus photo grading. The study included 25 patients with type 1 and 93
patients with type 2 diabetes (age 32+/-10 and 65+9 years, respectively),
The statistical evaluations were based on one eye per patient,
Results: Follow-up time was 5.5+/-2.4 years (mean+/-SD). Complications with
in 1/3 ODD from the centre of the macula were seen in 4% (1/23) of eyes of
patients with type 1 diabetes, compared to 26% (20/76) of eyes among patien
ts with type 2 diabetes (p=0.02), Hard exsudates before treatment mere more
common in type 2 than in type 1 diabetic eyes, 70/82 vs. 11/23 (p<0.001),
In all eps, hard exsudates were more often associated with subretinal fibro
sis or atrophic creep (35/133 eyes) than diffuse oedema (5/44 eyes) (p=0.04
),
Conclusion: Photocoagulation for clinically significant macular oedema with
hard exudates, particularly when subfoveally located, was more often assoc
iated,vith subretinal fibrosis or atrophic creep of the pigment epithelium
than photocoagulation of oedema without hard exudates, Hard exudates as web
as complications after photocoagulation were more common ill type 2 than i
n type 1 diabetes, resulting in poorer visual outcome in this group of pati
ents.